Related Experiment Videos
Management of microinvasive cervical cancers.
1Department of Obstetrics and Gynecology, Mayo Clinic Jacksonville, Florida 32224, USA. Sevin.BerndUwe@Mayo.edu
Seminars in Surgical Oncology
|May 4, 1999
Summary
Management of microinvasive cervical cancer (MIC) guidelines vary. Conservative treatment is possible for early-stage MIC without lymphovascular space invasion (LVSI), while hysterectomy is recommended for more advanced cases.
Area of Science:
- Gynecologic Oncology
- Cervical Cancer Management
- Surgical Oncology
Background:
- Management of microinvasive carcinoma of the cervix (MIC) remains controversial.
- Past treatment protocols for MIC have lacked clear definition.
- Current approaches require careful consideration of invasion depth and lymphovascular space invasion (LVSI).
Purpose of the Study:
- To clarify the management strategies for microinvasive carcinoma of the cervix.
- To delineate treatment options based on invasion depth and LVSI.
- To address fertility preservation concerns in MIC patients.
Main Methods:
- Review of existing literature and clinical guidelines for MIC management.
- Analysis of treatment outcomes based on histopathological findings (invasion depth, LVSI).
- Consideration of patient-specific factors, including fertility preservation.
Main Results:
- Microinvasive carcinoma of the cervix with invasion
- For MIC with LVSI and invasion up to 5 mm, hysterectomy and pelvic lymphadenectomy are recommended.
- Treatment modifications are considered for patients desiring fertility preservation.
Conclusions:
- Conservative management is feasible for select early-stage MIC cases.
- Surgical intervention (hysterectomy with lymphadenectomy) is indicated for more advanced MIC.
- Individualized treatment plans are crucial, especially for fertility-sparing approaches in MIC.